American Society for Transplantation and Cellular Therapy names president
Click Here to Manage Email Alerts
Miguel-Angel Perales, MD, has been named president of American Society for Transplantation and Cellular Therapy for 2023-2024.
Perales — chief of the adult bone marrow transplantation service at Memorial Sloan Kettering Cancer Center and professor of medicine at Weill Cornell Medical College — will direct the society’s new strategic plan and provide more science focus to help advance treatment options, according to a press release.
Perales has been a member of ASTCT since 2001. He has served on the society’s board of directors since 2017.
“I have enjoyed serving on the ASTCT board of directors, and I am honored to serve as president this year,” Perales said in the release. “In my practice, my patients have a variety of hematologic malignancies and are in need of an allogeneic transplant or cellular therapy. The goal of my practice, research, and now as president of ASTCT is to further advocate for our patients and support our field by advancing the science and further providing educational opportunities for our members.”
Perales’ research focus includes improving outcomes for patients undergoing stem cell transplantation, including reducing risk for complications, relapse and graft-versus-host disease. He also is conducting translational research to study new strategies to improve immune system recovery after transplant.
Perales is chair of Alliance for Clinical Trials in Oncology’s transplantation and cell-based therapies committee. He also is a member of the board of directors of Be The Match (National Marrow Donor Program).
He has held leadership positions with Center for International Blood and Marrow Transplant Research, as well as Blood and Marrow Transplantation Clinical Trials Network.
Click Here to Manage Email Alerts